Picture EBD Group BIO-Europe Spring 2021 Digital 650x80
Organisation › Details

EcoR1 Capital LLC

EcoR1 Capital LLC is a fundamental biotechnology-focused investment advisory firm. Based in San Francisco, EcoR1 evaluates and selects extraordinary biotechnology companies that are pursuing the highest quality science and demonstrate strong business fundamentals. Like the EcoR1 restriction enzyme which helped to transform the biomedical field, EcoR1 seeks to help move medical research forward through investments into compelling biotech companies that are developing promising new solutions for untreated diseases. *


Period Start 2018-04-09 existent
Products Industry finance
  Industry 2 LIFE SCIENCES
Region Region San Francisco, CA
  Country United States (USA)
  City n. a. San Francisco, CA
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Dewpoint Therapeutics. (1/30/19). "Press Release: Dewpoint Therapeutics Launches with $60 Million Series A to Advance Proprietary Platform for Drugging Condensates". Cambridge, MA.
Record changed: 2021-02-21


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for EcoR1 Capital LLC

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

» top